Target Name: LOC105375670
NCBI ID: G105375670
Review Report on LOC105375670 Target / Biomarker Content of Review Report on LOC105375670 Target / Biomarker
LOC105375670
Other Name(s): Uncharacterized LOC105375670, transcript variant X1 | LOC105375670 variant X1 | uncharacterized LOC105375670

LOC105375670: A Potential Drug Target or Biomarker

LOC105375670, also known as Uncharacterized LOC105375670 (transcript variant X1), is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. The molecule is derived from the genomic region of chromosome 6p21.3 and has been shown to play a role in the regulation of gene expression.

Recent studies have suggested that LOC105375670 may function as a negative regulator of the gene encoding the protein p16INK4a. p16INK4a is a key regulator of the cell cycle and has been implicated in various cellular processes, including cell division, apoptosis, and tissue homeostasis. The deregulation of p16INK4a has been associated with various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

LOC105375670 has been shown to interact with p16INK4a and can inhibit its activity. This interaction between LOC105375670 and p16INK4a suggests that the molecule may have potential as a drug target or biomarker for various diseases associated with p16INK4a dysfunction.

In addition to its potential as a drug target, LOC105375670 has also been identified as a potential biomarker for various diseases. The molecule has been shown to be expressed in a variety of tissues and has been used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The potential drug target for LOC105375670 is its ability to regulate p16INK4a activity, which has been shown to play a role in the development and progression of various diseases. p16INK4a has been implicated in the development of cancer, including breast, ovarian, and prostate cancers. It has also been implicated in the development of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases.

In addition to its potential as a drug target or biomarker, LOC105375670 has also been shown to have potential as a therapeutic agent. The molecule has been shown to be expressed in various tissues and has been shown to have protective effects against various stressors, including chemotherapy and radiation.

In conclusion, LOC105375670 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its interaction with p16INK4a and its potential as a therapeutic agent make it a promising candidate for the development of new treatments for various diseases associated with p16INK4a dysfunction. Further research is needed to fully understand the role of LOC105375670 in disease development and to determine its safety and efficacy as a drug or biomarker.

Protein Name: Uncharacterized LOC105375670

The "LOC105375670 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105375670 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105375672 | LOC105375683 | LOC105375690 | LOC105375704 | LOC105375712 | LOC105375716 | LOC105375721 | LOC105375725 | LOC105375730 | LOC105375733 | LOC105375739 | LOC105375741 | LOC105375743 | LOC105375745 | LOC105375751 | LOC105375753 | LOC105375755 | LOC105375779 | LOC105375785 | LOC105375787 | LOC105375805 | LOC105375825 | LOC105375836 | LOC105375855 | LOC105375856 | LOC105375861 | LOC105375875 | LOC105375896 | LOC105375903 | LOC105375911 | LOC105375914 | LOC105375920 | LOC105375922 | LOC105375925 | LOC105375928 | LOC105375931 | LOC105375938 | LOC105375943 | LOC105375951 | LOC105375962 | LOC105375974 | LOC105375976 | LOC105375977 | LOC105375983 | LOC105375984 | LOC105375990 | LOC105375999 | LOC105376001 | LOC105376014 | LOC105376017 | LOC105376035 | LOC105376081 | LOC105376107 | LOC105376110 | LOC105376136 | LOC105376139 | LOC105376156 | LOC105376157 | LOC105376158 | LOC105376161 | LOC105376169 | LOC105376171 | LOC105376177 | LOC105376187 | LOC105376193 | LOC105376196 | LOC105376205 | LOC105376206 | LOC105376208 | LOC105376211 | LOC105376214 | LOC105376219 | LOC105376223 | LOC105376225 | LOC105376234 | LOC105376244 | LOC105376247 | LOC105376250 | LOC105376253 | LOC105376270 | LOC105376287 | LOC105376326 | LOC105376344 | LOC105376356 | LOC105376360 | LOC105376361 | LOC105376372 | LOC105376375 | LOC105376387 | LOC105376391 | LOC105376397 | LOC105376400 | LOC105376407 | LOC105376412 | LOC105376413 | LOC105376422 | LOC105376435 | LOC105376440 | LOC105376442 | LOC105376481